Aug. 27 at 1:50 PM
$RBOT $AMIX Both have medical devices with huge market potential in pre-commercial stage.
$AMIX is more advanced - has already shown succeed in humans in proof-of-concept trial, has finalized design for preclinical trials, has cash burn rate of about 25% of
$RBOT, much lower market cap and has secured ATM financing.
